Anti-gene therapy: the use of ribozymes to inhibit gene function.

[1]  T. Reynolds,et al.  T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.

[2]  B. Naroditsky,et al.  The fowl adenovirus type 1 (CELO) virus-associated RNA-encoding gene: a new ribozyme-expression vector. , 1995, Gene.

[3]  W. Gerlach,et al.  Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. , 1995, Nucleic acids research.

[4]  T. Cech,et al.  Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA. , 1995, RNA.

[5]  E. Gilboa,et al.  Inhibition of HIV-1 in CEM cells by a potent TAR decoy. , 1995, Gene therapy.

[6]  B. Sullenger.  Colocalizing ribozymes with substrate rnas to increase their efficacy as gene inhibitors , 1995, Applied biochemistry and biotechnology.

[7]  J. D. Thompson,et al.  Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter. , 1995, Nucleic acids research.

[8]  R. Christoffersen,et al.  Ribozymes as human therapeutic agents. , 1995, Journal of medicinal chemistry.

[9]  D. Curiel,et al.  Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. , 1995, Cancer research.

[10]  H. Ertl,et al.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses , 1995, Journal of virology.

[11]  M. Strauss,et al.  Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library , 1995, Molecular and cellular biology.

[12]  D. Forget,et al.  Construction of a ribozyme directed against human interleukin-6 mRNA: evaluation of its catalytic activity in vitro and in vivo. , 1994, Blood.

[13]  O. Yamada,et al.  Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells. , 1994, Virology.

[14]  J. Rossi,et al.  Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. , 1994, Gene.

[15]  T. Cech,et al.  Ribozyme-mediated repair of defective mRNA by targeted trans-splicing , 1994, Nature.

[16]  R. Riek,et al.  Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA. , 1994, Biochemistry.

[17]  T. Dorai,et al.  Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme. , 1994, Molecular pharmacology.

[18]  E. Poeschla,et al.  Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. , 1994, Human gene therapy.

[19]  A. Wellstein,et al.  Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth. , 1994, The Journal of biological chemistry.

[20]  A. Altman,et al.  Construction and characterization of lck- and fyn-specific tRNA: ribozyme chimeras. , 1994, Molecular immunology.

[21]  P. Holm,et al.  Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. , 1994, British Journal of Cancer.

[22]  C. Benz,et al.  In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation. , 1994, Nucleic acids research.

[23]  R. Rubenstein,et al.  Ribozyme mediated degradation of β-amyloid peptide precursor mRNA in COS-7 cells , 1994 .

[24]  G. Hobom,et al.  Ribozyme mediated destruction of influenza A virus in vitro and in vivo , 1994, Journal of medical virology.

[25]  T. Dorai,et al.  Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. , 1994, Cancer research.

[26]  V. A. Flørenes,et al.  Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. , 1994, Cancer research.

[27]  R. Pictet,et al.  Can hammerhead ribozymes be efficient tools to inactivate gene function? , 1994, Nucleic acids research.

[28]  T. Cech,et al.  Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. , 1993, Science.

[29]  W. James,et al.  Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. , 1993, Nucleic acids research.

[30]  E. Reddy,et al.  Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. , 1993, Oncogene.

[31]  M. Perricaudet,et al.  Activation of HIV-specific ribozyme activity by self-cleavage. , 1993, Nucleic acids research.

[32]  A. Banerjea,et al.  Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates. , 1992, Nucleic acids research.

[33]  M. Martin,et al.  Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression , 1992, Journal of virology.

[34]  S. Read,et al.  Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme , 1991, Journal of virology.

[35]  T. Lee,et al.  Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication , 1990, Molecular and cellular biology.

[36]  Eli Gilboa,et al.  Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication , 1990, Cell.

[37]  J. Rossi,et al.  Ribozymes as potential anti-HIV-1 therapeutic agents. , 1990, Science.

[38]  T. Cech,et al.  Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena , 1982, Cell.